Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
321.73
403.21
418.92
372.33
313.56
510.95
700.77
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
321.73
403.21
418.92
372.33
313.56
510.95
700.77
Raw Material Cost
229.83
294.61
304.46
259.08
221.11
281.77
494.22
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
89.79
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
34.76
30.60
47.48
52.36
56.90
68.12
57.66
Selling and Distribution Expenses
93.57
97.98
123.14
116.60
183.17
265.24
341.23
Other Expenses
-2.24
-1.91
-2.94
-3.04
-3.47
-3.65
-8.67
Total Expenditure (Excl Depreciation)
335.76
404.07
445.67
397.59
426.46
578.60
896.18
Operating Profit (PBDIT) excl Other Income
-14
-0.8999999999999999
-26.7
-25.299999999999997
-112.89999999999999
-67.69999999999999
-195.39999999999998
Other Income
171.39
78.10
19.01
19.87
21.72
196.80
-1,105.52
Operating Profit (PBDIT)
174.28
105.54
27.30
27.00
-63.58
167.77
-1,460.52
Interest
34.76
30.60
47.48
52.36
56.90
68.12
57.66
Exceptional Items
-11.33
-3.32
49.01
-66.19
-58.06
-19.91
-316.38
Gross Profit (PBDT)
91.90
108.60
114.46
113.25
92.45
229.18
206.55
Depreciation
31.76
37.14
40.40
43.77
45.63
51.34
87.01
Profit Before Tax
96.43
34.49
-11.56
-135.32
-224.16
28.40
-1,921.56
Tax
0.12
0.25
0.31
-2.63
4.12
1.12
-0.31
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
96.31
34.24
-11.88
-132.69
-228.28
27.27
-1,920.67
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
96.31
34.24
-11.88
-132.69
-228.28
27.27
-1,920.67
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
-0.58
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
96.31
34.24
-11.88
-132.69
-228.28
27.27
-1,921.25
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
0.0
Reserves
1,120.29
972.18
580.87
301.27
432.96
660.41
633.06
Earnings per share (EPS)
0.13
0.05
-0.02
-0.25
-0.43
0.05
0.0
Diluted Earnings per share
0.13
0.05
-0.02
-0.25
-0.43
0.05
0.0
Operating Profit Margin (Excl OI)
-8.97%
-2.4%
-7.66%
-9.84%
-41.75%
-15.73%
-63.07%
Gross Profit Margin
39.84%
17.76%
6.88%
-24.59%
-56.94%
15.61%
-261.79%
PAT Margin
29.93%
8.49%
-2.84%
-35.64%
-72.8%
5.34%
-274.08%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -20.21% vs -3.75% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 181.58% vs 387.39% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -89.42% vs 230.12% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 13.73% vs -35.58% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Zhejiang Yatai Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
321.73
0
321.73
Other Operating Income
0.00
0.00
0.00
Total Operating income
321.73
0
321.73
Raw Material Cost
229.83
0
229.83
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
34.76
0
34.76
Selling and Distribution Expenses
93.57
0
93.57
Other Expenses
-2.24
0.00
-2.24
Total Expenditure (Excl Depreciation)
335.76
0
335.76
Operating Profit (PBDIT) excl Other Income
-14.03
0.00
-14.03
Other Income
171.39
0
171.39
Operating Profit (PBDIT)
174.28
0
174.28
Interest
34.76
0
34.76
Exceptional Items
-11.33
0
-11.33
Gross Profit (PBDT)
91.90
0
91.90
Depreciation
31.76
0
31.76
Profit Before Tax
96.43
0
96.43
Tax
0.12
0
0.12
Provisions and contingencies
0
0
0.00
Profit After Tax
96.31
0
96.31
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
96.31
0
96.31
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
96.31
0
96.31
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,120.29
0
1,120.29
Earnings per share (EPS)
0.13
0
0.13
Diluted Earnings per share
0.13
0
0.13
Operating Profit Margin (Excl OI)
-8.97%
0%
0.00
-8.97%
Gross Profit Margin
39.84%
0%
0.00
39.84%
PAT Margin
29.93%
0%
0.00
29.93%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 32.17 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -20.21% vs -3.75% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 9.63 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 181.58% vs 387.39% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.29 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -89.42% vs 230.12% in Dec 2024
Annual - Interest
Interest 3.48 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 13.73% vs -35.58% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -8.97%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






